Novel Therapy Delays Muscle Atrophy In Lou Gehrigs Disease Model | Latest News RSS feed

Novel Therapy Delays Muscle Atrophy In Lou Gehrigs Disease Model - Latest News


Novel therapy delays muscle atrophy in Lou Gehrig's disease model

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study. Researchers found high levels of the protein -- called mitofusion ... read more

Novel therapeutic approach alleviates ALS-related muscular atrophy in mouse models

muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig's, the new study suggests supplementing it could be a novel therapeutic approach for the d... read more

Symptoms of Lou Gehrig's Disease may be Reduced by Spinal Cord Protein

Mitofusion -2 or Mfn2, a protein found in the spinal cord, may prevent nerve degeneration, muscle ... an effective therapy to help delay the symptoms of Lou Gehrig's disease.’ "We found a way to allev... read more

Looking for another news?


Gene Therapy Delays Death in Mouse With Symptoms of Lou Gehrig's Disease

Newswise — It's not a cure, but a novel form of gene therapy has delayed symptoms and almost doubled life expectancy in mice with the equivalent of Lou Gehrig's disease ... in muscle, the benefit is m... read more


Changes to specific MicroRNA involved in development of Lou Gehrig's disease

A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig's disease ... a virus carrying the novel miR126-5p, and found that the mice had reco... read more

Israeli Scientists Identify New Mechanism in ALS

A new Tel Aviv University study has identified a previously unknown mechanism involved in the development of Lou Gehrig’s disease ... virus carrying the novel miR126-5p, and found that the mice had re... read more

3 Fascinating Small-Cap Biotech Stocks To Watch

It has a sound business model ... muscle activator, is in its Phase 3 under Special Protocol Assessment with the FDA. It is a potential treatment for heart failure which affects more than 6M people in ... read more

Slowing degenerative nerve disease

‘Improved motor performance' Although the treatment ... Lou Gehrig’s disease. CMT symptoms commonly include weakness of the foot and lower leg muscles, leading to a high-stepped gait with frequent tri... read more

Team finds melatonin delays ALS symptom onset and death in mice

Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease ... a finding that cou... read more

Gene Therapy Prolongs Survival, Slows Disease Progression in ALS Mice

report in the August 8 issue of Science that a novel gene therapy approach prolonged survival and slowed disease progression in mice with ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig' ... read more

Top 20 Stem Cell Stocks For 2015.

Top 20 Stem Cell Stocks for 2015 ... Neuralstem's first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral scle... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us